Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Neuropharmacology|March 16, 2026
Targeting the mTOR Pathway with Natural Products: A Potential Therapeutic Approach for Autism Spectrum DisordersTayebeh Noori, Seyede Zahra Hosseini, Seyede Darya Alavi, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 9, 2025
Protective effects of polydatin amphiphilic chitosan nanocarriers against an aluminum chloride-induced model of Alzheimer's disease in rats: relevance to its anti-inflammatory and antioxidant effectsSeyede Nazanin Zarneshan, Elham Arkan, Amir Kiani, et al.
Frontiers in Pharmacology|December 15, 2025
Targeting L-arginine/NO/cGMP/K<sub>ATP</sub> pathway by phytochemicals: therapeutic applications and clinical perspectivesSeyede Zahra Hosseini, Fatemeh Abbaszadeh, Seyede Darya Alavi, et al.
Frontiers in Pharmacology|May 2, 2025
Polydatin attenuates Alzheimer's disease induced by aluminum chloride in rats: evidence for its antioxidant and anti-inflammatory effectsSeyede Nazanin Zarneshan, Sajad Fakhri, Amir Kiani, et al.
Iranian Journal of Basic Medical Sciences|October 27, 2023
Synthesis and evaluation of the effects of solid lipid nanoparticles of ivermectin and ivermectin on cuprizone-induced demyelination via targeting the TRPA1/NF-kB/GFAP signaling pathwayTayebeh Noori, Ahmad Reza Dehpour, Seyede Darya Alavi, et al.
Iranian Journal of Pharmaceutical Research : IJPR|July 15, 2024
The Protective Effects of <i>Pistacia Atlantica</i> Gum in a Rat Model of Aluminum Chloride-Induced Alzheimer's Disease via Affecting BDNF and NF-kBMohammad Mehdi Gravandi, Seyede Zahra Hosseini, Seyede Darya Alavi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 20, 2020
The role of glycogen synthase kinase 3 beta in multiple sclerosisTayebeh Noori, Ahmad Reza Dehpour, Antoni Sureda, et al.
Pageof 1